IPP Bureau
Satish Pandurang Samant appointed CEO of Vineet Laboratories
By IPP Bureau - October 16, 2023
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Mankind Pharma appoints Prateek Dubey as President - Global CHRO
By IPP Bureau - October 16, 2023
Prateek has more than 23 years of rich experience in Human Resource
Ipca appoints Hitesh Kumar Maheshwari as President – R&D (Formulations)
By IPP Bureau - October 16, 2023
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Zydus appoints Punit Patel as President and CEO, Americas
By IPP Bureau - October 16, 2023
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
By IPP Bureau - October 16, 2023
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
ImmunoACT announces the approval of India's first CAR-T cell therapy 'NexCAR19'
By IPP Bureau - October 16, 2023
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities
By IPP Bureau - October 16, 2023
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
Evonik and Shandong Vland Biotech form JV in China with focus on gut health products for animals
By IPP Bureau - October 14, 2023
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
Philips Visual Patient Avatar pioneers at-a-glance patient data for faster, better decision-making in the operating room
By IPP Bureau - October 14, 2023
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations
By IPP Bureau - October 14, 2023
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
Venus Remedies expands reach with the launch of Elores in Ecuador
By IPP Bureau - October 14, 2023
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis
By IPP Bureau - October 13, 2023
The composition of ORAAL is protected by a granted patent in India until November 2033
Lupin gets tentative approval from USFDA for Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution
By IPP Bureau - October 13, 2023
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Ichnos Sciences inks agreement with Astria Therapeutics for OX40 antagonist monoclonal antibody portfolio
By IPP Bureau - October 13, 2023
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
IMI 5.0 campaign with special focus on improvement of Measles and Rubella vaccination coverage
By IPP Bureau - October 13, 2023
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
